Genenta Science SPA - ADRGNTA
13F holders, Q2 2025 (June 30)5holders
1new positions
1sold out
$3.39avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Genenta Science SPA - ADR (GNTA) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were AlTi Global, Inc. ($791K), Allianz SE ($713K) and Algebris (uk) Ltd. ($310K).
- Company
- Genenta Science SPA - ADR
- CUSIP
- 36870W100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 1 | $361 |
All 13F filers, Q1 2025 → Q2 2025: 1,482 shares bought and 1,491 shares sold, net −9 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| AlTi Global, Inc. | 0.02% | No change | 200,288 | $791K |
| Allianz SE | 0.02% | Add +0.2% | 234,050 | $713K |
| Algebris (uk) Ltd. | 0.05% | No change | 100,000 | $310K |
| Morgan Stanley | 0.00% | Reduce -41.2% | 2,000 | $6K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 982 | $3K |
"% of holder's portfolio" is GNTA's weight in each manager's 13F, not the share of Genenta Science SPA - ADR the manager owns.